Healthcare & Life Science

KO client Pluto Bio, the leading AI-powered platform for computational biology, recently raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies. According to the announcement, the round includes participation from new investor Kickstart, alongside existing investor Silverton Partners and…

For life sciences startups, many groundbreaking innovations start in university labs. But transforming that research into real-world impact requires navigating the often-complex process of university technology licensing. At Boulder Startup Week 2025, KO partner Brad Schoenfeld joined the University of Colorado’s Annalissa Philbin to share practical guidance from both the…

KO client Whitecap Biosciences, which is developing two innovative therapies for potential use in glaucoma and geographic atrophy, was recently acquired by Bausch + Lomb, a leading global eye health company to strengthen its expanding clinical stage pipeline. “Glaucoma and geographic atrophy can cause severe vision loss, with many patients…

Selling a business is a huge milestone for many founders and entrepreneurs, and the timing and preparation for a transaction are critical to maximizing success in a merger or acquisition. In our recent M&A webinar with KO’s Jennifer Rosenthal and GLC Advisors’ David Bluth, we explored essential strategies for business…

KO client Okogen, a clinical stage ophthalmic pharmaceutical company specializing in innovative eyecare solutions, recently announced the successful closing of $3.3 million in financing. According to the announcement, the funding will advance the company through the completion of the Phase 2b clinical program for acute infectious conjunctivitis (AIC) and the…

KO client ClinOne, which connects, informs, and empowers participants, care partners, and sites in clinical trials with a true single platform for trial awareness, consent management, and participant experience and retention, was recently acquired by uMotif, one of the clinical research technology market’s fastest-growing companies. “We’re excited to integrate our…

KO client Cloudbreak Pharma, an innovative clinical-stage ophthalmology biotechnology company, recently announced that it has entered into a licensing agreement with Santen, a specialized company dedicated to eye health, to develop, manufacture, and commercialize its topical pterygium treatment. Cloudbreak founder and CEO Jinsong Ni said: “We are excited to partner…

KO client Calorify, a metabolic testing startup, recently announced that it has raised nearly $500,000 in a pre-seed round to expand its work with clinical trials, medical practices, and professional sports teams. With the funding, Calorify plans to execute its go-to-market plan for its metabolic testing kit that the company…